[1]
Cómbita, A. et al. 2013. Evaluation of the immune response to human papillomavirus types 16, 18, 31, 45 and 58 in a group of Colombian women vaccinated with the quadrivalent vaccine. Revista Colombiana de Cancerología. 17, 3 (Sep. 2013), 103–110.